rs121912732
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_170665.4(ATP2A2):āc.2300A>Gā(p.Asn767Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N767D) has been classified as Pathogenic.
Frequency
Consequence
NM_170665.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A2 | NM_170665.4 | c.2300A>G | p.Asn767Ser | missense_variant | 15/20 | ENST00000539276.7 | NP_733765.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A2 | ENST00000539276.7 | c.2300A>G | p.Asn767Ser | missense_variant | 15/20 | 1 | NM_170665.4 | ENSP00000440045.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461428Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727030
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Darier disease, acral hemorrhagic type Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 1999 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 01, 2015 | The N767S missense variant in the ATP2A2 gene has been reported previously in association with Darier disease (Green et al., 2013; Hamada et al., 2007; Ruiz-Perez et al., 1999). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position within the M5 transmembrane domain that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown that N767S, which occurs in a calcium-binding residue, has a damaging effect on the protein, showing 59% of wild-type expression levels, 67% Ca2+-ATPase activity, and 28% Ca2+-transport activity (Miyauchi et al., 2006). Missense variants in the same (N767D) and nearby residues (L763V, S765L, G769R) have been reported in the Human Gene Mutation Database in association with Darier disease (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, we interpret N767S as a pathogenic variant. - |
Keratosis follicularis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Oct 18, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at